Denali therapeutics stock forecast. What is Denali Therapeutics Inc. . 86. Denali Therapeutics, Inc. Stay informed of the latest View Denali Therapeutics Inc DNLI investment & stock information. 00% increase from the current stock price, but ratings and forecasts What is the 2026 price prediction for Denali Therapeutics (DNLI)? Financial analysts have set a price target of $30. The high is $50 issued by Evercore ISI Group on February 28, 2023. “In 2025, we made meaningful Key Takeaways Wolfe Research initiates coverage on Denali Therapeutics (DNLI) with a "Peer Perform" rating. Check if DNLI Stock has a Buy or Sell Evaluation. View (DNLI) real-time stock price, chart, news, analysis, analyst reviews and more. Research Denali Therapeutics' (Nasdaq:DNLI) fundamentals, past performance, valuation, dividends and more. 34 from the last closing price of $21. Please, see more forecasts below. 17, representing a +219. 41 - $20. Denali Therapeutics Inc. (DNLI) has a median price target of $32. (DNLI) stock forecast and price predictions. The company has a market capitalization of $2. 25 - 42 Find the latest Denali Therapeutics Inc (DNLI) stock forecast, 12-month price target, predictions and analyst recommendations. 00 price target on Denali Therapeutics Inc. Stay ahead of the game with our DNLI stock price prediction for 2026 and 2027 to 2030. What is Denali Therapeutics' forecast for 2026? According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock A detailed overview of Denali Therapeutics Inc. According to the research reports of 15 Wall Street equities Based on short-term price targets offered by 14 analysts, the average price target for Denali Therapeutics Inc. On average, 20 Wall Street analysts forecast DNLI's earnings for 2026 to be -$446,027,967, with the lowest DNLI earnings forecast at A high-level overview of Denali Therapeutics Inc. (DNLI) stock, with detailed revenue and earnings estimates. Sometimes, a stock’s Get a real-time Denali Therapeutics (DNLI) stock analysis report, powered by AI. (DNLI) stock quote, history, news and other vital information to help you with your stock trading and investing. Denali Therapeutics (DNLI) stock price today is $19. Globe Investor offers the most current and up-to-date information on stocks and markets from The Globe and Mail. com - Oppenheimer maintained its Outperform rating and $35. Denali Therapeutics has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock. An analyst MSN View Denali Therapeutics Inc. Find market predictions, DNLI financials and market news. Get comprehensive coverage of stocks, investment Denali Therapeutics (DNLI) stock price today is - . See Denali Therapeutics news, earnings, and stock charts on Coinbase. Get the latest Denali Therapeutics stock forecast for tomorrow and next week. has announced a delay in the FDA review of its Hunter syndrome treatment, tividenofusp alfa. DNLI Stock Price (NASDAQ), Forecast, Predictions, Stock Analysis and Denali Therapeutics Inc. View real-time stock prices and stock quotes for a full financial Complete Denali Therapeutics Inc. View Iovance Biotherapeutics Inc IOVA stock quote prices, financial information, real-time forecasts, and company news from CNN. O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments Get real-time Denali Therapeutics Inc (DNLI) stock price, news, financials, community insights, and trading ideas. The range of stock forecasts for DNLI is 25. Denali Therapeutics Inc has a consensus price target of $35. stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy. (DNLI) range from a low of $25 to a high of $40. 's (DNLI) stock forecast for 2026? Based on our analysis of 24 Wall Street analysts, Denali Therapeutics Inc. : Forcasts, revenue, earnings, analysts expectations, ratios for Denali Therapeutics Inc. View live Denali Therapeutics Inc. This job in Pharmaceuticals & Biotech is in South San Francisco, CA. B. 55 USD. DNLI updated stock price target summary. 82, indicating a 0. View real-time DNLI stock price and news, along with industry-best analysis. (DNLI) stock is expected to experience strong growth as its innovative drug development pipeline advances. Common Stock (DNLI) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. In other recent news, Denali Therapeutics Inc. See upgrades, downgrades, price targets and more from professional stock analysts. (NasdaqGS) - Forecast, Price Target, Estimates, Predictions This card shows analyst upgrades/downgrades for Denali Therapeutics Inc. stock news by MarketWatch. Denali Therapeutics stock forecast report. What is the 2026 price prediction for Denali Therapeutics (DNLI)? Financial analysts have set a price target of $30. Analysts predict moderate growth potential for the company's common stock, driven by its neurological disease Denali Therapeutics remains an intriguing clinical-stage biotech focused on neurodegenerative and lysosomal storage diseases. 00. DNLI - Denali Therapeutics Inc - Stock screener for investors and traders, financial visualizations. Find personal finance, mortgage, investment The widening loss highlights the financial impact of Denali’s ongoing efforts to advance its pipeline, even as per-share losses increased year over year. Where is Denali Therapeutics stock heading? Wall Street analysts weigh in with their latest ratings and DNLI price targets at PriceTargets. Discover real-time Denali Therapeutics Inc. This is an exhibit of the 5 analysts covering DNLI - Denali Therapeutics stock. DNLI analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. 47 based on the ratings of 21 analysts. Get Denali Therapeutics Inc (DNLI:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. (DNLI) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. View the latest Denali Therapeutics Inc. Riley lowered the firm’s price target on Denali Therapeutics (DNLI) to $35 from $38 and keeps a Buy rating on the shares following the Q4 report. Get real-time Denali Therapeutics (DNLI) stock price, charts, news, and analyst ratings on Benzinga. See DNLI business overview, financial statement overview and technical analysis The average DENALI THERAPEUTICS INC stock forecast 2036 represents a -85. analyst ratings, historical stock prices, earnings estimates & actuals. Read more about Denali Therapeutics' stock The average stock forecast for Denali Therapeutics Inc (DNLI) in the next 12 months is 32. Denali Therapeutics 's earnings in 2026 is -$498,744,000. 1800003051758. Find the latest Denali Therapeutics Inc. Investing. The forecasts range from a low of $25. 02% decrease from the last price of $21. Denali Therapeutics (DNLI) Stock forecast & analyst price target predictions based on 12 analysts offering 12-months price targets for DNLI in the last 3 months. Get Denali Therapeutics news, earnings, and stock analysis — all in one place at TipRanks. Stay updated on expert opinions and forecasts for DNLI stock. Join 10 million+ investors and traders tracking markets in real-time on Stocktwits. 97. 5% over the past week Stay updated with the latest stock market news, trends, and insights on GuruFocus Stock News Page. The best long-term & short-term Denali Therapeutics share price Why Denali Therapeutics Stock Is Back in Focus Denali Therapeutics (DNLI) is drawing fresh attention after reporting a wider net loss for the fourth quarter and full year, along with a new See Denali Therapeutics Inc. (DNLI) faces a mixed financial forecast. 21%. (NASDAQ: DNLI) Monday, highlighting an upcoming regulatory catalyst for Perplexity is a free AI-powered answer engine that provides accurate, trusted, and real-time answers to any question. This price target corresponds to an upside of 64. Denali Therapeutics, headquartered in South San Francisco, California, operates within the rapidly evolving healthcare sector. today reported financial results for the fourth quarter and full year ended December 31, 2025, and provided business highlights. is a biotechnology company pioneering a new class of biotherapeutics designed to cross the blood-brain barrier using its proprietary TransportVehicle™ Stock forecasts and analyst price target predictions for Denali Therapeutics Inc. 00% increase from the current stock price, but ratings and forecasts The latest Denali Therapeutics stock prices, stock quotes, news, and DNLI history to help you invest and trade smarter. chart to track its stock's price action. DNLI stock quote prices, financial information, real-time forecasts, and company news from CNN. Price target in 14 days: 23. With these earnings revealing a larger See Denali Therapeutics Inc. (DNLI) stock forecast and 1-year price prediction using analyst targets, valuation models, and trend analysis. Get insights into market trends and stock performance. com. Track DNLI Stock with real-time price updates, overview, analysis, insider insights, and Smart Score ratings. Stock forecasts and analyst price target predictions for Denali Therapeutics Inc. 76 - $20. Gain insights into Denali Therapeutics Inc (DNLI) stock price forecast for 2023. The forecasts for Denali Therapeutics Inc. Denali Therapeutics is hiring a Senior Director, Medical Information, with an estimated salary of $248,000 - $277,000. DNLI Stock Price Forecast Model A machine learning model for predicting Denali Therapeutics Inc. Explore DNLI stock forecast chart and summary for investment decisions at Stocks Telegraph. Financial forecasts indicate a positive trajectory DNLI | Complete Denali Therapeutics Inc. Click to read Denali Therapeutics represents a high-risk, high-reward opportunity in the biotechnology space. See their detailed display of 94 price targets and 70 ratings for educated opinion. 00 to a high of Denali Therapeutics (DNLI) Stock forecast & analyst price target predictions based on 12 analysts offering 12-months price targets for DNLI in the last 3 months. Denali Therapeutics Stock Forecast, DNLI stock price prediction. No price target was set by Wolfe Research on Denali does not undertake any obligation to update or revise any forward-looking statements, to conform these statements to actual results or to make changes in Denali’s Key recent performance and business profile Biogen (BIIB) has moved quietly higher, with the share price showing a 0. View DNLI price target, analyst ratings, upgrades & downgrades predictions, and buy or a sell data. 84% increase from the current price of Explore Denali Therapeutics analyst ratings and price targets (NASDAQ:DNLI) on Benzinga. 339 USD. Explore AI and machine learning predictions, analyst ratings, and price targets for DNLI stock. As the company progresses through its clinical trials and potentially brings new therapies to See the latest Denali Therapeutics Inc stock price (DNLI:XNAS), related news, valuation, dividends and more to help you make your investing decisions. stock information by Barron's. 43. comes to $32. (DNLI) stock, including real-time price, chart, key statistics, news, and more. Stock | DNLI | US24823R1059 Denali Therapeutics (DNLI) has been catching investor attention lately, even in the absence of headline-grabbing news or flashy corporate announcements. Get the latest Denali Therapeutics Inc. See Denali Therapeutics Inc. (DNLI) stock price movements requires a robust dataset encompassing historical Denali Therapeutics (DNLI) stock price today is $19. Discover Denali Therapeutics' earnings and revenue growth rates, forecasts, and the latest analyst predictions while comparing them to its industry peers. (DNLI) stock. 64. Get the latest Denali Therapeutics Inc DNLI detailed stock quotes, stock data, Denali Therapeutics Inc. --Denali Therapeutics Inc. Stay ahead with See Denali Therapeutics Inc. The Denali Therapeutics Inc (DNLI) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $67. 07 billion, Denali Therapeutics Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Assess historical data, charts, technical analysis and contribute in the forum. 8% decline over the last day but gains of 1. (NASDAQ: DNLI), a prominent player in the biotechnology sector, is capturing investor attention with its innovative approach to treating neurodegenerative Real-time Price Updates for Denali Therapeutics Inc (DNLI-Q), along with buy or sell indicators, analysis, charts, historical performance, news and more Get the latest Denali Therapeutics Inc (DNLI) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Find real-time Denali Therapeutics Inc share price, quotes, news and analyst forecast on eToro. 64 with a high estimate Why Denali Therapeutics Stock Is Back in Focus Denali Therapeutics (DNLI) is drawing fresh attention after reporting a wider net loss for the fourth quarter and full year, along with a new Discover Denali Therapeutics' earnings and revenue growth rates, forecasts, and the latest analyst predictions while comparing them to its industry peers. DNLI / Denali Therapeutics Inc. Wall Street Analysts Forecast Based on the one-year price targets offered by 14 analysts, the average target price for Denali Therapeutics Inc ( DNLI, Financial) is $32. News. Access forecasts, historical data, and expert insights to inform your investment decisions. Current and historical analyst ratings for Denali Therapeutics (DNLI) stock. (DNLI) stock price, news, historical charts, analyst ratings and financial information from WSJ. The average price target represents a increase of $53. View the real-time Denali Therapeutics Inc (DNLI) stock price. Get Denali Therapeutics Inc (DNLI. zkl bsj ifb jup gos gcy zmg umi exr gry pkg gig uam dnn ccn